作者：
Thiébaud,Picart [1]
;
Delphine,Poncet [2]
;
Marc,Barritault [3]
;
Luc,Bauchet [4]
;
Sonia,Zouaoui [5]
;
Jacques,Guyotat [3]
;
Mathieu,Gabut [4]
;
Frédéric,Fina [2]
;
Jérôme,Honnorat [3]
;
Dominique,Figarella-Branger [6]
;
Johan,Pallud [7]
;
François,Ducray [8]
;
David,Meyronet [6]
;
French Brain Tumor Database [7]
;
ANOCEF [1]
作者单位：
Departments of Tumoral and Vascular Neurosurgery.
[1]
Cancer Initiation and Tumoral Cell Identity Department, Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286.
[2]
Claude Bernard University Lyon 1, Villeurbanne.
[3]
Institute of Pathology, Neuropathology, and Molecular Biology, East Hospital Group, Hospices Civils de Lyon, Bron.
[4]
Institut NeuroMyoGene Institute-INSERM U1217/UMR CNRS 5310.
[5]
Department of Neurosurgery, Montpellier University Medical Center.
[6]
FBTDB (French Brain Tumor DataBase), ICM.
[7]
Institute of Functional Genomics, Montpellier University, CNRS, INSERM, Montpellier.
[8]
APHM, Department of Pathology and Neuropathology, Marseille University Hospital - Timone Hospital, APHM.
[9]
Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon.
[10]
MELIS Institute-Team Synaptopathies and Autoantibodies, INSERM U1314/UMR CNRS 5284, Lyon.
[11]
Aix-Marseille Univ, CNRS, INP, Neurophysiopathol. Inst. Marseille.
[12]
Department of Neurosurgery, GHU Paris, Site Sainte-Anne.
[13]
University of Paris.
[14]
IMA-Brain, INSERM U894, Institute of Psychiatry and Neurosciences of Paris, Paris, France.
[15]
DOI
10.1097/PAS.0000000000001996
PMID
36418240
发布时间
2023-02-15
换一批
换一批
